Project description
Decreasing resistance to an important treatment for tuberculosis
Infectious diseases are caused by bacteria, viruses, fungi, and parasites. There are vaccines to prevent infection or medicines to kill the organisms but an increasing number of organisms are becoming resistant to treatments. Tuberculosis (TB) is caused by Mycobacterium tuberculosis. In many cases, these bacteria are resistant to multiple drugs, some with lethal results. The EU-funded TRIC-TB project is exploring a promising way to boost the effectiveness of treatment for multidrug-resistant TB. With a focus on restoring sensitivity to an existing line of treatment, scientists hope to improve patient outcomes regardless of initial resistance status at the time of infection.
Fields of science
Programme(s)
Topic(s)
Funding Scheme
IMI2-RIA - Research and Innovation actionCoordinator
4057 Basel
Switzerland
See on map
Participants (2)
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
59000 Lille
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
28760 Tres Cantos Madrid
See on map